Pontifax
VC · Herzliya (Israel)
Sign up free to access full profile and submit your pitch.
About
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with $1.2 billion under management.We seek transformative, cutting-edge life sciences technologies at all development stages. Our portfolio comprises of about 100 companies that develop breakthrough solutions to substantial unmet needs.INVESTING IN BREAKTHROUGHINNOVATIONS ONLYPontifax invests in breakthrough innovation regardless of therapeutic area or development stage. We establish our own companies as well as partner with existing management to nurture start-ups to maturity. Pontifax takes a hands-on approach in its portfolio management and is deeply involved in charting the course of each company.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of Pontifax
Other investors that have backed the same portfolio companies as Pontifax. Expand any entry to see the shared portfolio companies.
- 11 shared
Shared portfolio companies
- Adcendo ApS
- Adicet Bio, Inc.
- Eledon Pharmaceuticals, Inc.
- Fore Biotherapeutics Inc.
- ForSight VISION6, Inc.
- Keros Therapeutics, Inc.
- Mereo BioPharma Group plc
- Nutrinia Ltd.
- Purple Biotech Ltd
- Tisbury Pharmaceuticals, Inc.
- Vanqua Bio, Inc.
- 8 shared
Shared portfolio companies
- 6 shared
Shared portfolio companies
- 5 shared
Shared portfolio companies
- 4 shared
Shared portfolio companies
- 4 shared
Shared portfolio companies
- 4 shared
Shared portfolio companies
- 4 shared
Shared portfolio companies
- Hairstetics Ltd.
- Levation Pharma Ltd
- Lutris Pharma Ltd
- Raziel Therapeutics Ltd.
- 3 shared
Shared portfolio companies
- Adcytherix B.V.
- Adicet Bio, Inc.
- Lutris Pharma Ltd
